TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...

TD Cowen reinitiated coverage on Tempus AI Inc (NASDAQ:TEM) with a Buy rating, increasing the price target to $74 from a previous target. The stock, currently trading at $61.85, has shown remarkable ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors bought 51,813 call options on the company. This is an increase of approximately ...

Tempus AI, known for its AI-driven precision medicine,... Tuesday - Analysts at TD Cowen have initiated coverage on Tempus AI Inc (NASDAQ:TEM) stock with a Buy rating and have set a price target ...

周三，TD Cowen重新开始对Tempus AI Inc (NASDAQ:TEM)的跟踪报告，给予"买入"评级，并将目标价从此前的目标价上调至74美元。该股目前交易价格为61.85美元，年初至今涨幅达83.2%。根据InvestingPro数据显示，分析师对TEM的目标价区间为50美元至70美元，综合建议倾向于买入。此次评级上调是在Tempus AI完成对Ambry Genetics的收购后做出 ...

Tempus AI , Inc. (NASDAQ: TEM )董事David R. Epstein近期出售了370股该公司A类普通股。这些股票于2025年2月3日以平均每股$53.31的价格售出，总价值约$19,724。此后，TEM股价已上涨至$69.18，这家市值$97.4亿的公司年初至今已实现105%的显著涨幅。 InvestingPro ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle.

SAP is also expected to benefit from decreased drags from IaaS and transactional products, and an average selling price (ASP) uplift from new AI/Data offerings. According to TD Cowen, the company ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle. Analysts ...